KEYTRUDA® (pembrolizumab) from Merck Awarded Prix Galien USA 2015 Best Biotechnology Product Award

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. META
2. NVDA
3. SPY
4. VRTX
5. LGND
6. ONON
7. USO
8. PSKY
9. MONC:IM
10. PTON

Go back to KEYTRUDA® (pembrolizumab) from Merck Awarded Prix Galien USA 2015 Best Biotechnology Product Award
Merck & Co. (NYSE: MRK) Delayed: 153.13 +3.63 (2.43%)
Previous Close $149.50    52 Week High $65.46 
Open $148.69    52 Week Low $47.97 
Day High $153.57    P/E 104.17 
Day Low $148.04    EPS $1.47 
Volume 2,416,175